Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies
Paolo Fagone(University of Catania), Ferdinando Nicoletti(University of Catania), Yehuda Shoenfeld(Weizmann Institute of Science), Carmelo Iacobello(Ospedale Cannizzaro), Rosella Ciurleo(Centro Neurolesi Bonino Pulejo), Placido Bramanti(Centro Neurolesi Bonino Pulejo), Klaus Bendtzen(Rigshospitalet), Concetta Ilenia Palermo(University of Catania), Salvo Danilo Lombardo(University of Catania)
Cited by 120
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Hydroxychloroquine: From Malaria to Autoimmunity
|Clinical Reviews in Allergy & Immunology|2011|612
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508